Laparoscopic Myomectomy with Fibroid 1 cm from Gestational Sac at 9 Weeks - Precautions

1. Is the Procedure Justified at All?

• Elective myomectomy is contraindicated during pregnancy. Berek & Novak's Gynecology states explicitly: "Any decision to perform a myomectomy in order to prevent problems during pregnancy should take into account the risks of surgery, anesthesia, postoperative adhesions, and an increased likelihood of subsequent cesarean delivery, along with concerns about discomfort, expense, and time away from work or family."
• Most fibroids do not increase significantly in size during pregnancy and the majority of pregnancies with fibroids proceed uneventfully.
• Acceptable indications for proceeding: pedunculated fibroid with torsion, refractory pain not responding to conservative management, or fibroid causing urinary/bowel obstruction.
• At 9 weeks, organogenesis is nearly complete but the uterus is highly vascular and the gestational sac is within a few millimeters of the planned dissection plane.

2. Preoperative Precautions

3. Intraoperative Precautions - Surgical Technique

3a. Vasopressin Injection

• Dilute vasopressin (20 units in 100 mL saline) injected into the myometrium/fibroid interface to achieve vasoconstriction and reduce blood loss.
• Caution in pregnancy: vasopressin can cause uterine contractions and placental vasoconstriction - inject slowly, use minimum effective dose, monitor fetal heart rate (FHR) continuously.
• Some experts prefer a tourniquet (pericervical or uterine artery temporary occlusion) over vasopressin in pregnant patients to avoid uterotonic effects.

3b. Incision Planning

• Avoid incising closer than 1 cm to the gestational sac - the 1 cm margin described IS the minimum safe zone.
• Transverse rather than longitudinal incisions are preferred (more ergonomic laparoscopic suturing, less risk of extending toward sac).
• Do not extend the incision toward the lower uterine segment if the sac is inferiorly located.

3c. Dissection

• Use blunt dissection in the fibroid capsule plane - avoid electrosurgery near the sac.
• The textbook specifically notes: "Bleeding vessels in the myometrial defect are desiccated sparingly with bipolar electrosurgical paddles, taking care not to devascularize the myometrium and interfere with wound healing."
• A study of 19 uterine rupture cases post-laparoscopic myomectomy found 16 of 19 used monopolar or bipolar energy for hemostasis - excessive electrosurgery is strongly implicated in poor wound healing and subsequent rupture.

3d. Hemostasis

• Prefer suture ligature over electrocautery for significant vessels in the myometrial bed.
• Limit bipolar energy to the minimum necessary; monopolar is preferred to be avoided near the gestational sac due to the spread of thermal injury.

3e. Multilayered Closure - THE MOST CRITICAL STEP

• Multi-layer myometrial closure is mandatory. The textbook analysis of rupture cases found:
  • 7/19 cases: uterine defect not repaired at all
  • 3/19 cases: single suture only
  • 4/19 cases: only one layer closed
  • Only 3/19 had multilayer closure - and these had the best outcomes
• Use delayed absorbable sutures (e.g., PDS 1-0 or 0) in 2-3 layers as needed for the defect depth.
• The serosa should be closed as a separate layer.
• Do not leave any dead space - dead space leads to hematoma, poor healing, and rupture risk.

3f. Pneumoperitoneum

• Keep CO2 insufflation pressure ≤12 mmHg (ideally 10 mmHg) - high intra-abdominal pressure reduces uterine blood flow and can cause fetal acidosis.
• Minimize operative time to reduce fetal CO2 exposure (CO2 crosses the placenta and can cause fetal respiratory acidosis).
• Use left lateral tilt (15°) to reduce aortocaval compression once the uterus is repositioned.

3g. Fetal Monitoring

• Continuous intraoperative FHR monitoring via transvaginal or transabdominal ultrasound - Doppler FHR probe can be draped into the sterile field.
• Post-induction baseline FHR should be documented.
• If bradycardia or decelerations occur, immediately lower IAP, release pneumoperitoneum, and place in left lateral tilt.

4. Tocolysis

• Prophylactic tocolysis (e.g., indomethacin 25 mg PR preoperatively, or nifedipine) is used by many centers, though evidence is limited.
• Intraoperative oxytocin should be avoided as it may promote contractions and threaten pregnancy continuity.
• Indomethacin (COX-2 inhibitor) is the preferred tocolytic at 9 weeks; MgSO4 is another option intraoperatively.
• Progesterone supplementation postoperatively (vaginal micronized progesterone 200-400 mg/day) may help maintain pregnancy.

5. Morcellation

• Contained morcellation only (bag system) must be used.
• Standard power morcellation without containment bag is prohibited.
• Many centers would opt for mini-laparotomy (3-4 cm) for fibroid extraction to avoid any morcellation risk in this setting.

6. Postoperative Precautions

7. Future Pregnancy Management (if current pregnancy is not lost)

• Scar surveillance: Serial ultrasound of the myometrial scar from the 2nd trimester onward.
• Uterine rupture risk at trial of labor after myomectomy: 0.47% (Berek & Novak's, p. 512-513) - but this applies to well-healed scars with multilayer closure; a scar with only one layer or excess electrosurgery is higher risk.
• 5 of 7 ruptures in a large series occurred before 36 weeks - hence close monitoring in the 3rd trimester.
• Elective cesarean at 37-38 weeks is standard practice.

Summary of Non-Negotiable Steps

1. Multilayer myometrial closure - the single most important factor preventing uterine rupture
2. Minimal electrosurgery for hemostasis - use sutures, not cautery, in the myometrial bed
3. Low-pressure pneumoperitoneum (≤12 mmHg)
4. Continuous fetal monitoring intraoperatively
5. Vasopressin used cautiously with uterotonic awareness
6. No extension of incision toward the 1 cm sac margin - if bleeding cannot be controlled safely, convert to open
7. Plan for cesarean delivery in this pregnancy

References: Berek & Novak's Gynecology (pp. 512-514, 523-529); PMID 42147617 (2026 case report: second-trimester uterine rupture after conservative myomectomy)